The promotion role of CRNDE on CRC cell proliferation and tumorigenesis may partly via epigenetically restraining DUSP5 and CDKN1A transcription by binding with EZH2 and inhibiting EZH2-mediated methylation modification of these target genes. Here, DUSP5 is linked to colorectal carcinoma.